p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Seminars in Cancer Biology · 2024-06 · 101 · 44-57
DOI: 10.1016/j.semcancer.2024.05.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024-06. Verfasst von Youyi Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China; Provincial key Laboratory …. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53, Signal Transduction, Aging. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 206 Literaturangaben.
Abstract (Originalsprache)
A wealth of evidence has emerged that there is an association between aging, senescence and tumorigenesis. Senescence, a biological process by which cells cease to divide and enter a status of permanent cell cycle arrest, contributes to aging and aging-related diseases, including cancer. Aging populations have the higher incidence of cancer due to a lifetime of exposure to cancer-causing agents, reduction of repairing DNA damage, accumulated genetic mutations, and decreased immune system efficiency. Cancer patients undergoing cytotoxic therapies, such as chemotherapy and radiotherapy, accelerate aging. There is growing evidence that p53/MDM2 (murine double minute 2) axis is critically involved in regulation of aging, senescence and oncogenesis. Therefore, in this review, we describe the functions and mechanisms of p53/MDM2-mediated senescence, aging and carcinogenesis. Moreover, we highlight the small molecular inhibitors, natural compounds and PROTACs (proteolysis targeting chimeras) that target p53/MDM2 pathway to influence aging and cancer. Modification of p53/MDM2 could be a potential strategy for treatment of aging, senescence and tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China; Provincial key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hos…
- Department of Medicine, Oasis Medical Research Center, Watertown, MA 02472, USA. Electronic address: peterwang618@hotmail.com.
Zitieren
APA
Huang, Y., Che, X., Wang, P. W., & Qu, X. (2024). p53/MDM2 signaling pathway in aging, senescence and tumorigenesis. Seminars in Cancer Biology, 101, 44-57. https://doi.org/10.1016/j.semcancer.2024.05.001
Vancouver
Huang Y, Che X, Wang PW, Qu X. p53/MDM2 signaling pathway in aging, senescence and tumorigenesis. Seminars in Cancer Biology. 2024;101:44-57. doi:10.1016/j.semcancer.2024.05.001
BibTeX
@article{Huang2024,
author = {Huang, Youyi and Che, Xiaofang and Wang, Peter W and Qu, Xiujuan},
title = {p53/MDM2 signaling pathway in aging, senescence and tumorigenesis},
journal = {Seminars in Cancer Biology},
year = {2024},
volume = {101},
pages = {44--57},
doi = {10.1016/j.semcancer.2024.05.001}
}
EUVIMED